Quantority
AIGENSYN logo

AIGENSYN AIGENSYN · perps

$0.0243

Price · 1h

AIGENSYN across exchanges

ExchangeFunding APROpen interestOI share
BBinance logoBinance-142.26%$3.98M81%
BBybit logoBybit-83.22%$911.7K19%

Funding annualized per venue interval; open interest is the latest reading per exchange. No fresh per-venue reading from OKX, Bitget right now — the cross-exchange totals above still include every venue's last data.

Interpretation

AIGENSYN is displaying a sharp deleveraging pattern across its derivatives markets. Open interest has contracted significantly, falling -13.7% over the past 24 hours and -39.2% over the past week, indicating broad position unwinding rather than fresh leverage entry. The absolute open interest level of $4.8M reflects a relatively modest notional size overall, constraining the scale of systemic risk.

The funding rate environment presents a striking anomaly: the aggregated funding APR stands at -160.60%, placing it at the 21st percentile of the last 90 days' range. This deeply negative rate—where shorts pay longs—suggests that despite recent deleveraging, short positioning remains elevated relative to demand from buyers, creating a structural imbalance that incentivizes shorts to close. The liquidation imbalance of +0.00 over 24 hours shows balanced two-way pressure, with neither longs nor shorts experiencing concentrated forced closures.

The leverage risk score of 29 reflects relatively benign positioning fragility. Combined with the ongoing contraction in open interest and the absence of directional liquidation clustering, AIGENSYN's derivatives landscape appears to be normalizing from a crowded state rather than building fresh leverage concentration. The negative funding rate, while historically uncommon for the asset, is functioning as a natural brake on short accumulation.

About this analysis: written from the served metrics only and validated against the data — methodology · editorial policy. Not financial advice.Written 13 Jul, 06:00 · Data live to 13 Jul, 11:15 UTC
AIGENSYN FundingAIGENSYN Open InterestAIGENSYN LiquidationsAIGENSYN Risk
Disclosure: some exchange links are affiliate links — we may earn a commission at no cost to you. Data is for research only and is not financial advice.